3H Health Investment logo

3H Health Investment

Asia, Hong Kong Island, Hong Kong, Cyberport

Description

3H Health Investment is a dedicated healthcare private equity fund focusing on China.

Investor Profile

3H Health Investment has made 8 investments, with 2 in the past 12 months and 13% as lead.

Stage Focus

  • Series B (38%)
  • Series C (38%)
  • Series A (25%)

Country Focus

  • China (75%)
  • United States (25%)

Industry Focus

  • Biotechnology
  • Health Care
  • Biopharma
  • Pharmaceutical
  • Medical
  • Life Science
  • Medical Device
  • Robotics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does 3H Health Investment frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 3
Yonghua Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 2
ALAN AMC
Asia, Beijing, China, Beijing
Co-Investments: 1
Legend Capital
Asia, Beijing, China, Beijing
Co-Investments: 3
Bain Capital Life Sciences
North America, Massachusetts, United States, Boston
Co-Investments: 2
Octagon Capital Advisors
North America, New York, United States, New York
Co-Investments: 3
Quan Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 3
Verition Fund Management
North America, Connecticut, United States, Greenwich
Co-Investments: 2
Lilly Asia Ventures
Asia, Shanghai, China, Shanghai
Co-Investments: 3
Boyu Capital
Asia, Beijing, China, Beijing
Co-Investments: 2

What are some of recent deals done by 3H Health Investment?

Timberlyne Therapeutics

San Diego, California, United States

Timberlyne Therapeutics is a biopharmaceutical company that develops therapies for autoimmune diseases.

BiopharmaBiotechnologyHealth Care
Series AJan 9, 2025
Amount Raised: $180,000,000
Angitia Biopharmaceuticals

Guangzhou, Guangdong, China

Angitia Biopharmaceuticals is a global biotechnology company focusing on the discovery and development of innovative therapeutics.

BiopharmaBiotechnologyHealth CareMedical
Series CDec 11, 2024
Amount Raised: $120,000,000
Angitia Biopharmaceuticals

Guangzhou, Guangdong, China

Angitia Biopharmaceuticals is a global biotechnology company focusing on the discovery and development of innovative therapeutics.

BiopharmaBiotechnologyHealth CareMedical
Series BOct 19, 2023
Amount Raised: $46,000,000
Alebund Pharmaceuticals

Shanghai, Shanghai, China

Alebund Pharmaceuticals is a biopharmaceutical company dedicated to developing innovative therapies for the treatment of renal diseases.

BiotechnologyLife SciencePharmaceutical
Series CApr 12, 2023
Amount Raised: $29,091,755
Edge Medical Robotics

Shenzhen, Guangdong, China

Edge Medical Robotics is a surgical robot platform company focused on design, R&D, and commercialization of advance medical devices.

Health CareMedical DeviceRobotics
Series CNov 5, 2021
Amount Raised: $200,000,000
Alebund Pharmaceuticals

Shanghai, Shanghai, China

Alebund Pharmaceuticals is a biopharmaceutical company dedicated to developing innovative therapies for the treatment of renal diseases.

BiotechnologyLife SciencePharmaceutical
Series BSep 13, 2021
Amount Raised: $54,500,000
Haihe Biopharma

Shanghai, Shanghai, China

Haihe Biopharma is a biopharmaceutical company that develops cancer anti-tumour drugs.

BiopharmaBiotechnologyHealth CareMedicalPharmaceutical
Series BJul 24, 2020
Amount Raised: $171,005,942
Citrine Medicine

Cambridge, Massachusetts, United States

Citrine Medicine is a rare disease-focused pharmaceutical firm.

Pharmaceutical
Series AJul 13, 2020
Amount Raised: $80,000,000